INTRODUCTION
Nanotechnology has gradually evolved towards commercial applications in various fields including advanced materials, computational sciences, bio-analytics and surface sciences. Nanotechnology can potentially make big impacts on biomedicine and ultimately global human society. How can we utilize the recent progress in the forefronts of nanotechnology to make a significant impact on global health? This is tough to answer, since nanotechnology by nature encompasses a large number of interdisciplinary fields from broad areas which need to work closely together. Why are technologies at the nanoscale so important in the biosciences? Living systems and nanoscale objects fundamentally share a common scale at the molecular level ( Fig. 1) . Building blocks of almost all living systems constitute interacting bio-molecules at the molecular scale. Thus advances in nanotechnologies are bound to provide an interface and have a direct application in the life sciences. In this review, we highlight emerging areas such as quantum dots and nanoparticles, nanoliter fluidic systems, label free detection, single molecule, and single cell analysis (Fig. 2) . These rapidly growing areas can also influence our fundamental understanding of biology and medicinal sciences including tissue engineering (Fig. 3) .
What advances have been made at the individual biomolecule level? It is now possible to detect trace amounts of bio-materials inside living organisms. This has opened a new avenue of detection with minimal sample preparation, increased accuracy and shortened the total required experimental time. Such a novel approach further enables us to explore much broader experimental states to look for new solutions. High-throughput measurements in large-scale experiments at both the cellular and bio-molecular level are more readily available than before and this can illuminate what one researcher aptly called "biological dark matter". Advances in the synthesis of tunable nano-materials which interact with biological matter in novel ways have led to more efficient discoveries of new labeling and therapeutic agents (Miele et al., 2012; Zhang et al., 2013) .
SYSTEMS BIOLOGY
How would a nanotechnological approach change new drug development if we could precisely model a biological system as a whole? So far, a reductionist's approach has been mostly used to understand biological processes by taking small pieces of system at a time, and looking at a small number of interrelations with other entities. An emerging viewpoint in biology is to globally map out a large number of processes and interconnections in a given biological system (Kirschner, 2005) . This knowledge can be used, for example, to evaluate new methods for identifying drug target molecules. Systems biology fundamentally takes a different approach to consider a biological entity as an information processing network with each individual module responding to signals from various nodes (Ideker, 2004) . Thus biological complexity, which has plagued our understanding of how living systems behave in response to a given externally or internally generated signal, can now be ad-
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Two basic paradigm shifts are suggested to make this transition feasible. The first avenue for change is to mine large amounts of data in numerous experimental conditions via highthroughput technology. Such experiments rely heavily on automated technologies to enable probing the large numbers of state spaces of stimuli and responses of a biological system. The second avenue would use computational and mathematical tools, which play crucial roles in building these large scale models and enable the testing of various hypotheses in a given system network. A systems biology approach can provide us a new way to understand the interactions among elements uncovering emergent properties in intracellular and intercellular signaling through quantitative measurements, modeling and reconstruction. For example, dynamically changing levels of mRNA and protein affect protein-to-protein interactions and DNA-toprotein interactions. The accurate quantitation of biological information in a high-throughput manner is central to systems biology (Aderem, 2005; Chuang et al., 2010) . The four essential features in measurements of biological information are quantitative, global, dynamic, and systematic perturbation of networks.
Several high-throughput technologies are progressively becoming adopted in systems biology areas. Automated DNA sequencers, microarrays for global gene expression profiles, and mass spectrometry and others have been the workhorses for high-throughput generation of inter-relationships in systems biology networks. A comprehensive understanding of detailed biological networks would be necessary to reliably predict biological and phenotypical consequences. However, there are several challenges. For instance, conventionally used experimental tools alone cannot provide enough spatio-temporal resolution in measurements.
Since systems biology requires large amounts of information and data to predict responses to environmental cues, it is common to iteratively refine details in a given model. Maerkl and Quake (2007) recently introduced an integrated microfluidic device for high-throughput measurement of molecular affinities to build inter-relation networks. The technique depends on mechanically induced trapping with microfluidic valves. Attomoles of DNA and transcription factors were used per data point to obtain ~40,000 data points to mea-sure molecular interactions of transcription factors with DNA belonging to helixloop-helix family. Another technique integrates digital PCR with microfluidic manipulation and microarrays to acquire information from a single bacteria (Ottesen et al., 2006) , which is not feasible in traditional cell culture based approaches. This allows the building of gene inventory in a population of mixed bacterial species obtained from a natural environment. Such highthroughput data retrieval on the phylogenetic scale adds information at another level of hierarchy in the biological network.
TECHNOLOGICAL ADVANCES Multifunctional nanoparticles and nanomaterials

Quantum dots
A quantum dot (QD) is the most basic nanostructure which spatially confines the conduction band, valence band and excitation at a single point. QDs have been applied to in vitro live cell imaging, in vivo imaging in animals and medical diagnostics (Cheki et al., 2013; Michalet et al., 2005; Stroh et al., 2005) .
Cell surface receptors, as small as 50 nm, can be labeled with QDs. Furthermore, the controllable hydrodynamic diameter (HD) and surface charge of nano-crystals are useful in biomedical imaging of tissue and sentinel lymph nodes. In vivo imaging of a tumor would be possible by the use of QD515 (HD = 4.4 nm) and QD574 (HD = 8.2 nm) (Jain, 2005) . Some challenges include the lack of accurate quantification and the inability to detect multiple proteins simultaneously. The detection of multiple QDs with tunable size in a single imaging setup would provide rich information sets with a single experimental run.
For biological imaging applications, fluorescent nanoparticles and nano-crystals have been already commercialized. Moreover, other simple elements can be used as building blocks. For example, Bruchez et al. (1998) developed nanorods used in DNA conjugation and electrophoresis of Au nano-crystals and DNA tiles organized by nano-crystals. It is further possible to engineer multi-functional nanoparticles. Integrated multifunctional nanoparticles would be useful in targeting agents and diagnostic imaging with remote sensing, triggering, and drug delivery. In vivo phage display exploits differences in the tumor endothelium (Ruoslahti, 2002) . Nanoparticles functionalized with homing peptides can also target tumors: for example, F3-QDs and LyP-1-QDs target different structures in xenograft tumor (Akerman et al., 2002) . Protease-activated QDs, in which the blocker peptide coating on QDs is cleaved by protease, can be used to modulate the cellular uptake of QDs (Zhang et al., 2006b) . Matrix metalloprotease-cleavable polyethylene glycol (PEG) nanoparticles can be accumulated in xenograft tumors over non-cleavable controls, and be localized for better tumor targeting (Harris et al., 2008) . A programmable drug delivery is also possible (Wagner, 2007) . DNA can be heated by the induction of an external electromagnetic field, which first triggers DNA release from nanoparticles, then multistage release, and finally in vivo release. This process is reversible and allows triggered self-assembly for sensing application.
Toxicity of quantum dots
One challenge in using nanomaterials such as QDs for in vivo studies is its potential long-term toxicity and its effect on in vivo fate (Sayes et al., 2006) . The toxicity and the potential environmental effects of QDs need to be addressed before these agents can be used for in vivo imaging. For example, the renal clearance of QDs depends on its electrostatic property or hydrodynamic radius and this is an important consideration in designing QDs or nanoparticles for in vivo use (Choi et al., 2007) . Several innovative strategies have been developed to reduce or eliminate toxicity of these nanomaterials. For instance, it was demonstrated that intercellular concentration of QDs could be made nontoxic by coating the surface of the QDs with terminalfunctionalized polyethylene glycol (PEG) (Zhang and MonteiroRiviere, 2009). Since QDs have strong surface coating dependence, PEG coating could improve biocompatibility. The dramatic reduction of the QD uptake into cells at low temperatures (4°C) indicates that the intracellular localization is energydependent (Damalakiene et al., 2013) . For extracellular use at the cell surface receptor binding, it was shown that a concentration of 5 to 20 nM should be used for minimal toxicity of QDs. It must also be noted that QDs can degrade at the acidic pH of 4.5 to 5 in the lysosome. Thus, cell death was shown to be highly dependent on the environmental exposure concentration, type of QDs and experimental conditions (Hardman, 2006) .
